Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP299532.RAVN7_AbxlUwORQrbNMp_iyjfkLD-OCipIBcODdyhRLI0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP299532.RAVN7_AbxlUwORQrbNMp_iyjfkLD-OCipIBcODdyhRLI0130_assertion type Assertion NP299532.RAVN7_AbxlUwORQrbNMp_iyjfkLD-OCipIBcODdyhRLI0130_head.
- NP299532.RAVN7_AbxlUwORQrbNMp_iyjfkLD-OCipIBcODdyhRLI0130_assertion description "[To verify whether enhanced substrate-level phosphorylation increases viability and adenosine 5'-triphosphate (ATP) content of cells with neuropathy, ataxia, and retinitis pigmentosa/maternally inherited Leigh syndrome (NARP/MILS) mitochondrial DNA mutations and ATP synthase dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299532.RAVN7_AbxlUwORQrbNMp_iyjfkLD-OCipIBcODdyhRLI0130_provenance.
- NP299532.RAVN7_AbxlUwORQrbNMp_iyjfkLD-OCipIBcODdyhRLI0130_assertion evidence source_evidence_literature NP299532.RAVN7_AbxlUwORQrbNMp_iyjfkLD-OCipIBcODdyhRLI0130_provenance.
- NP299532.RAVN7_AbxlUwORQrbNMp_iyjfkLD-OCipIBcODdyhRLI0130_assertion SIO_000772 19667215 NP299532.RAVN7_AbxlUwORQrbNMp_iyjfkLD-OCipIBcODdyhRLI0130_provenance.
- NP299532.RAVN7_AbxlUwORQrbNMp_iyjfkLD-OCipIBcODdyhRLI0130_assertion wasDerivedFrom befree-20140225 NP299532.RAVN7_AbxlUwORQrbNMp_iyjfkLD-OCipIBcODdyhRLI0130_provenance.
- NP299532.RAVN7_AbxlUwORQrbNMp_iyjfkLD-OCipIBcODdyhRLI0130_assertion wasGeneratedBy ECO_0000203 NP299532.RAVN7_AbxlUwORQrbNMp_iyjfkLD-OCipIBcODdyhRLI0130_provenance.